The home oxygen therapy market is undergoing a notable shift. From 2014 to 2023, the percentage of fee-for-service (FFS) Medicare beneficiaries utilizing oxygen has fallen from 3.44% to 2.51%. Adjusted for the shift of beneficiaries from traditional Medicare to Medicare Advantage, this holds true as well. This is a notable dynamic considering the number of Medicare eligible patients continues growing daily.
